Compensation of the Board of Directors for 2023
The following table discloses the compensation paid to the members of the Board of Directors for financial year 2023 while performing services for medmix:
|
|
|
2023 |
||||||
|
thousands of CHF |
|
Cash fees |
|
Restricted share unit (RSU) plan 3) |
|
Social security contributions 5) |
|
Total |
|
Rob ten Hoedt, Chairman 2) |
|
131 |
|
150 |
|
21 |
|
302 |
|
Barbara Angehrn 2) |
|
70 |
|
65 |
|
11 |
|
146 |
|
Daniel O. Flammer 2) |
|
70 |
|
65 |
|
11 |
|
146 |
|
David Metzger 2) |
|
68 |
|
65 |
|
11 |
|
144 |
|
Greg Poux-Guillaume 1) |
|
95 |
|
60 |
|
12 |
|
167 |
|
Marco Musetti 1) |
|
78 |
|
73 |
|
12 |
|
163 |
|
René Willi 2) |
|
70 |
|
65 |
|
11 |
|
146 |
|
Board of Directors |
|
582 |
|
543 |
|
89 |
|
1’214 |
The following table discloses the compensation paid to the members of the Board of Directors for financial year 2022 while performing services for medmix:
|
|
|
2022 |
||||||
|
thousands of CHF |
|
Cash fees |
|
Restricted share unit (RSU) plan 4) |
|
Social security contributions 5) |
|
Total |
|
Greg Poux-Guillaume, Chairman 1) |
|
150 |
|
150 |
|
23 |
|
323 |
|
Barbara Angehrn 2) |
|
49 |
|
65 |
|
9 |
|
123 |
|
Daniel O. Flammer 2) |
|
49 |
|
65 |
|
9 |
|
123 |
|
David Metzger 2) |
|
45 |
|
60 |
|
8 |
|
113 |
|
Marco Musetti 1) |
|
74 |
|
73 |
|
12 |
|
159 |
|
René Willi 2) |
|
49 |
|
65 |
|
9 |
|
123 |
|
Rob ten Hoedt 2) |
|
54 |
|
73 |
|
10 |
|
137 |
|
Jill Lee 6) |
|
19 |
|
0 |
|
2 |
|
21 |
|
Board of Directors |
|
489 |
|
551 |
|
82 |
|
1’122 |
1) Member of the Board of Directors since September 20, 2021.
2) Member of the Board of Directors since April 12, 2022.
3) RSU awards granted in 2023. Grant price was CHF 21.57 (three-month volume weighted average share price) and fair value was CHF 20.65.
4) RSU awards granted in 2022. Grant price was CHF 32.74 (three-month volume weighted average share price) and fair value was CHF 32.08.
5) The amount includes mandatory social security contributions on the cash fees and estimated contributions on the RSU (based on their fair value at grant) paid by the company on behalf of the Board members.
6) Member of the Board of Directors from September 20, 2021 to April 12, 2022.
As of December 31, 2023 and 2022, respectively, there were no outstanding loans or credits granted to the members of the Board of Directors, former members of the Board of Directors or related parties. In 2023 and 2022, respectively, no compensation, loans or credits were granted to former members of the Board of Directors or related parties.
Reconciliation between the reported board compensation and the amount approved by the shareholders at AGM
At the AGM 2023, shareholders approved a maximum aggregate compensation amount of CHF 1'500'000 for the Board of Directors for the period of office from the 2023 AGM until the end of the 2024 AGM. The table below shows the reconciliation between the compensation that was/will be paid out for the periods of office and the maximum aggregate compensation amounts approved by the shareholders.
|
thousands of CHF |
|
Compensation earned during financial year as reported (A) |
|
Less compensation earned from Jan to AGM of financial year (B) |
|
Plus compensation accrued from Jan to AGM of year following financial year (C) |
|
Total compensation earned for the period from AGM to AGM of medmix (A-B+C) |
|
Amount approved by shareholders at respective AGM |
|
Ratio between compensation earned for the period from AGM to AGM versus amount approved by shareholders |
|
2023 AGM - 2024 AGM |
|
2023 |
|
January 01, 2023 to 2023 AGM medmix |
|
January 01, 2024 to 2024 AGM medmix |
|
2023 AGM to 2024 AGM |
|
2023 AGM |
|
2023 AGM |
|
Board of Directors Total |
|
1’214 |
|
202 |
|
197 |
|
1’208 |
|
1’500 |
|
80.6% |
|
|
|
Compensation earned during financial year as reported (A) |
|
Less compensation earned from Jan to AGM of financial year (B) |
|
Plus compensation accrued from Jan to AGM of year following financial year (C) |
|
Total compensation earned for the period from AGM to AGM of medmix (A-B+C) |
|
Amount approved by shareholders at respective AGM |
|
Ratio between compensation earned for the period from AGM to AGM versus amount approved by shareholders |
|
2022 AGM - 2023 AGM |
|
2022 |
|
January 01, 2022 to 2022 AGM medmix |
|
January 01, 2023 to 2023 AGM medmix |
|
2022 AGM to 2023 AGM |
|
2022 AGM |
|
2022 AGM |
|
Board of Directors Total |
|
1’122 |
|
82 |
|
150 |
|
1’188 |
|
1’500 |
|
79.2% |